• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管疾病住院后的再入院情况:对澳大利亚文献的范围综述

Readmissions following hospitalisations for cardiovascular disease: a scoping review of the Australian literature.

作者信息

Labrosciano Clementine, Air Tracy, Tavella Rosanna, Beltrame John F, Ranasinghe Isuru

机构信息

Health Performance and Policy Research Unit, Basil Hetzel Institute for Translational Research, 37A Woodville Road, Woodville South, SA 5011, Australia. Email:

Translational Vascular Function Research Collaborative, Basil Hetzel Institute for Translational Research, 37A Woodville Road, Woodville South, SA 5011, Australia. Email:

出版信息

Aust Health Rev. 2020 Feb;44(1):93-103. doi: 10.1071/AH18028.

DOI:10.1071/AH18028
PMID:30779883
Abstract

Objective International studies suggest high rates of readmissions after cardiovascular hospitalisations, but the burden in Australia is uncertain. We summarised the characteristics, frequency, risk factors of readmissions and interventions to reduce readmissions following cardiovascular hospitalisation in Australia. Methods A scoping review of the published literature from 2000-2016 was performed using Medline, EMBASE and Cumulative Index to Nursing and Allied Health Literature (CINAHL) databases and relevant grey literature. Results We identified 35 studies (25 observational, 10 reporting outcomes of interventions). Observational studies were typically single-centre (11/25) and reported readmissions following hospitalisations for heart failure (HF; 10/25), acute coronary syndrome (7/25) and stroke (6/25), with other conditions infrequently reported. The definition of a readmission was heterogeneous and was assessed using diverse methods. Readmission rate, most commonly reported at 1 month (14/25), varied from 6.3% to 27%, with readmission rates of 10.1-27% for HF, 6.5-11% for stroke and 12.7-17% for acute myocardial infarction, with a high degree of heterogeneity among studies. Of the 10 studies of interventions to reduce readmissions, most (n=8) evaluated HF management programs and three reported a significant reduction in readmissions. We identified a lack of national studies of readmissions and those assessing the cost and resource impact of readmissions on the healthcare system as well as a paucity of successful interventions to lower readmissions. Conclusions High rates of readmissions are reported for cardiovascular conditions, although substantial methodological heterogeneity exists among studies. Nationally standardised definitions are required to accurately measure readmissions and further studies are needed to address knowledge gaps and test interventions to lower readmissions in Australia. What is known about the topic? International studies suggest readmissions are common following cardiovascular hospitalisations and are costly to the health system, yet little is known about the burden of readmission in the Australian setting or the effectiveness of intervention to reduce readmissions. What does this paper add? We found relatively high rates of readmissions following common cardiovascular conditions although studies differed in their methodology making it difficult to accurately gauge the readmission rate. We also found several knowledge gaps including lack of national studies, studies assessing the impact on the health system and few interventions proven to reduce readmissions in the Australian setting. What are the implications for practitioners? Practitioners should be cautious when interpreting studies of readmissions due the heterogeneity in definitions and methods used in Australian literature. Further studies are needed to test interventions to reduce readmissions in the Australians setting.

摘要

目的 国际研究表明,心血管疾病住院后的再入院率很高,但澳大利亚的负担尚不确定。我们总结了澳大利亚心血管疾病住院后的再入院特征、频率、风险因素以及减少再入院的干预措施。方法 使用Medline、EMBASE和护理及联合健康文献累积索引(CINAHL)数据库以及相关灰色文献,对2000年至2016年发表的文献进行范围综述。结果 我们确定了35项研究(25项观察性研究,10项报告干预结果)。观察性研究通常为单中心研究(11/25),报告了心力衰竭(HF;10/25)、急性冠状动脉综合征(7/25)和中风(6/25)住院后的再入院情况,其他情况报告较少。再入院的定义不统一,采用了多种评估方法。再入院率最常报告的时间是1个月(14/25),范围从6.3%到27%,HF的再入院率为10.1 - 27%,中风为6.5 - 11%,急性心肌梗死为12.7 - 17%,研究之间存在高度异质性。在10项减少再入院的干预研究中,大多数(n = 8)评估了HF管理项目,3项报告再入院率显著降低。我们发现缺乏关于再入院的全国性研究,以及评估再入院对医疗系统成本和资源影响的研究,而且成功降低再入院率的干预措施也很少。结论 心血管疾病的再入院率很高,尽管研究之间存在大量方法学上的异质性。需要全国标准化的定义来准确衡量再入院情况,还需要进一步研究来填补知识空白并测试降低澳大利亚再入院率的干预措施。关于该主题已知的信息是什么?国际研究表明,心血管疾病住院后再入院很常见,且对卫生系统成本高昂,但对于澳大利亚背景下的再入院负担或减少再入院干预措施的有效性知之甚少。本文补充了什么?我们发现常见心血管疾病后的再入院率相对较高,尽管研究方法不同,难以准确衡量再入院率。我们还发现了几个知识空白,包括缺乏全国性研究、评估对卫生系统影响的研究以及在澳大利亚背景下很少有被证明能降低再入院率的干预措施。对从业者有什么启示?由于澳大利亚文献中使用的定义和方法存在异质性,从业者在解释再入院研究时应谨慎。需要进一步研究来测试降低澳大利亚再入院率的干预措施。

相似文献

1
Readmissions following hospitalisations for cardiovascular disease: a scoping review of the Australian literature.心血管疾病住院后的再入院情况:对澳大利亚文献的范围综述
Aust Health Rev. 2020 Feb;44(1):93-103. doi: 10.1071/AH18028.
2
Readmission and processes of care across weekend and weekday hospitalisation for acute myocardial infarction, heart failure or stroke: an observational study of the National Readmission Database.急性心肌梗死、心力衰竭或中风患者周末和工作日住院的再入院和治疗过程:国家再入院数据库的观察性研究。
BMJ Open. 2019 Aug 22;9(8):e029667. doi: 10.1136/bmjopen-2019-029667.
3
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
4
Disease management interventions for heart failure.心力衰竭的疾病管理干预措施。
Cochrane Database Syst Rev. 2019 Jan 8;1(1):CD002752. doi: 10.1002/14651858.CD002752.pub4.
5
Unplanned 30-day readmissions, comorbidity and impact on one-year mortality following incident heart failure hospitalisation in Western Australia, 2001-2015.2001-2015 年澳大利亚西部因心力衰竭入院的患者中,30 天内非计划性再入院、合并症及对一年死亡率的影响。
BMC Cardiovasc Disord. 2023 Jan 16;23(1):25. doi: 10.1186/s12872-022-03020-x.
6
Frequency, trends and institutional variation in 30-day all-cause mortality and unplanned readmissions following hospitalisation for heart failure in Australia and New Zealand.澳大利亚和新西兰心力衰竭住院患者 30 天全因死亡率和非计划性再入院的频率、趋势和机构差异。
Eur J Heart Fail. 2021 Jan;23(1):31-40. doi: 10.1002/ejhf.2030. Epub 2020 Nov 9.
7
A 5-year retrospective cohort study of unplanned readmissions in an Australian tertiary paediatric hospital.一项针对澳大利亚一家三级儿科医院非计划再次入院情况的5年回顾性队列研究。
Aust Health Rev. 2019 Jan;43(6):662-671. doi: 10.1071/AH18123.
8
Trends in unplanned readmissions over 15 years: a regional Australian perspective.15 年来计划性再入院趋势:澳大利亚地区视角。
Aust Health Rev. 2020 Apr;44(2):241-247. doi: 10.1071/AH18072.
9
Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia.心力衰竭、急性心肌梗死或肺炎患者住院后 30 天内再入院的诊断和时间。
JAMA. 2013 Jan 23;309(4):355-63. doi: 10.1001/jama.2012.216476.
10
Mortality and Readmission Following Hospitalisation for Heart Failure in Australia: A Systematic Review and Meta-Analysis.澳大利亚心力衰竭住院后的死亡率和再入院率:一项系统评价和荟萃分析
Heart Lung Circ. 2018 Aug;27(8):917-927. doi: 10.1016/j.hlc.2018.01.009. Epub 2018 Feb 5.

引用本文的文献

1
The impact of pay-for-performance incentives for stroke unit access on public hospital costs and use, Queensland, 2012-17: interrupted time series analysis.2012 - 2017年昆士兰州卒中单元使用绩效薪酬激励措施对公立医院成本及使用情况的影响:中断时间序列分析
Med J Aust. 2025 Mar 17;222(5):249-258. doi: 10.5694/mja2.52607. Epub 2025 Feb 25.
2
Feasibility of a brief, in-patient coping and sleep intervention to reduce potentially preventable readmission of cardiac patients to hospital.一项简短的住院应对与睡眠干预措施对于减少心脏病患者潜在可预防的再次入院情况的可行性。
Contemp Clin Trials Commun. 2023 Nov 10;36:101230. doi: 10.1016/j.conctc.2023.101230. eCollection 2023 Dec.
3
LACE Index to Predict the High Risk of 30-Day Readmission in Patients With Acute Myocardial Infarction at a University Affiliated Hospital.
预测某大学附属医院急性心肌梗死患者30天再入院高风险的LACE指数
Front Cardiovasc Med. 2022 Jul 11;9:925965. doi: 10.3389/fcvm.2022.925965. eCollection 2022.
4
Ability of the LACE Index to Predict 30-Day Readmissions in Patients with Acute Myocardial Infarction.LACE指数预测急性心肌梗死患者30天再入院的能力。
J Pers Med. 2022 Jun 30;12(7):1085. doi: 10.3390/jpm12071085.
5
LACE Index to Predict the High Risk of 30-Day Readmission: A Systematic Review and Meta-Analysis.预测30天再入院高风险的LACE指数:一项系统评价和荟萃分析。
J Pers Med. 2022 Mar 30;12(4):545. doi: 10.3390/jpm12040545.
6
The Impact of a Mobile App on Participation in Cardiac Rehabilitation and Understanding Barriers to Success: Comparative Cohort Study.一款移动应用程序对心脏康复参与度及成功障碍认知的影响:比较队列研究
JMIR Cardio. 2022 Jan 17;6(1):e24174. doi: 10.2196/24174.
7
The Association between Sleep Duration and Quality with Readmissions: An Exploratory Pilot-Study among Cardiology Inpatients.睡眠时间和质量与再入院之间的关联:一项针对心脏病住院患者的探索性试点研究。
Clocks Sleep. 2020 Apr 2;2(2):120-142. doi: 10.3390/clockssleep2020011. eCollection 2020 Jun.